1. Market Research
  2. > Pathology
Customer Support

Talk to Ahmad

+1 718 618 4302

Industries

About 500 reports for Lymphoma (page 1)

Purchase Reports From Reputable Market Research Publishers

Lymphoma Treatment Drugs Markets in China

  • $ 4000
  • October 2019
  • 206 pages

Developing Lymphoma Treatment Drugs is very important in curing Lymphoma illness.

  • Lymphoma
  • Pharmaceutical
  • China
  • Shenzhen Main Luck Pharmaceuticals Inc.
  • Zhejiang Hisun Pharmaceutical Co., Ltd.

Lymphoma Treatment Drugs Companies in China

  • $ 1800
  • October 2019
  • 71 pages

Developing Lymphoma Treatment Drugs is very important in curing Lymphoma illness.

  • Lymphoma
  • Pharmaceutical
  • China
  • Beijing Wintic Pharma Co., Ltd
  • Pfizer Inc.

Global Follicular Lymphoma Therapeutics Market 2018-2022

  • $ 2500
  • October 2018
  • 105 pages

Hoffmann-La Roche • Gilead • Merck About Follicular Lymphoma Follicular lymphoma is a subtype of B-cell non-Hodgkin lymphoma (NHL).

  • Lymphoma
  • Therapy
  • World
  • Market Size

The 2021-2026 World Outlook for Lymphoma Therapeutics

  • $ 995
  • November 2019
  • 299 pages

This study covers the world outlook for lymphoma therapeutics across more than ## countries.

  • Cancer
  • Lymphoma
  • Pathology
  • World
  • Demand

Global Burkitt Lymphoma Therapeutics Market 2018-2022

  • $ 2500
  • September 2018
  • 109 pages

Hoffmann-La Roche • Merck Sharp & Dohme • Novartis • Spectrum Pharmaceuticals About Burkitt Lymphoma Burkitt Lymphoma is one of the rare types of B-cell non-Hodgkin’s lymphoma.

  • Lymphoma
  • Therapy
  • World
  • Market Size

Global Diffuse Large B-Cell Lymphoma (DLBCL) Therapeutics Market 2018-2022

  • $ 2500
  • October 2018
  • 110 pages

Hoffmann-La Roche • Merck Sharp & Dohme • Novartis • Pfizer • Spectrum Pharmaceuticals About Diffuse Large B-Cell Lymphoma DLBCL is a cancer of B-lymphocytes.

  • Lymphoma
  • Therapy
  • World
  • Market Size

Global Lymphoma Drugs Market 2017-2021

  • $ 2500
  • June 2017
  • 86 pages

The aim of lymphoma treatment is to get rid of the lymphoma cells.

  • Cancer
  • Lymphoma
  • Celgene Corporation
  • Seattle Genetics, Inc.
  • Takeda Pharmaceutical Company Limited

NHL: Follicular Lymphoma Forecast and Market Analysis (FL) to 2026

  • $ 22000
  • January 2019
  • 510 pages

NHL: Follicular Lymphoma Forecast and Market Analysis (FL) to 2026 CONTENTS ## FORECAST: FOLLICULAR LYMPHOMA (Published on ## January 2019) ## OVERVIEW ## RECENT FORECAST UPDATES ## MARKET DYNAMICS ## FORECAST AND FUTURE TRENDS ## MARKET DEFINITION AND METHODOLOGY ## PRIMARY

  • Cancer
  • Lymphoma
  • Pathology
  • European Union
  • United States

Global Diffuse Large B Cell Lymphoma Drug Market, Dosage, Price & Clinical Pipeline Outlook 2024

  • $ 2400
  • March 2018
  • 280 pages

Diffuse Large B Cell Lymphoma ##. ## Introduction ##. ## Classification of Diffuse Large B Cell Lymphoma ##.

  • Cancer
  • Lymphoma
  • Therapy
  • World
  • Market Size

NHL: Diffuse Large B Cell Lymphoma Forecast and Market Analysis to 2034, Pharma Intelligence

  • $ 22000
  • October 2018
  • 475 pages

NHL: Diffuse Large B Cell Lymphoma Forecast and Market Analysis to 2034, Pharma Intelligence Table of Contents (Forecast, Treatment, Epidemiology Datapacks included) ## FORECAST: DIFFUSE LARGE B-CELL LYMPHOMA (Published on ## October 2018) ## OVERVIEW ## RECENT FORECAST UPDATES

  • Cancer
  • Lymphoma
  • Pathology
  • European Union
  • United States

Global Bruton’s Tyrosine Kinase (BTK) Inhibitors Market: Size & Forecast with Impact Analysis of COVID-19 (2020-2024)

  • $ 900
  • June 2020
  • 82 pages

B-cell lymphomas can be categorized into aggressive NHL, such as diffuse large B-Cell lymphoma (DLBCL), mantle cell lymphoma (MCL), and burkitt' s lymphoma (BL), and indolent NHL, such as chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma

  • Autoimmune Disease
  • Lymphoma
  • Therapy
  • World
  • AbbVie Inc.

NHL: Follicular Lymphoma Forecast and Market Analysis to 2025

  • $ 22000
  • April 2018
  • 229 pages

NHL: Follicular Lymphoma Forecast and Market Analysis to 2025 TABLE OF CONTENTS Forecast, Treatment, Epidemiology Datapacks included) & nbsp; ## FORECAST: FOLLICULAR LYMPHOMA (Published on ## April 2016) ## OVERVIEW ## EXECUTIVE SUMMARY ## MARKET OVERVIEW AND TRENDS ## METHODOLOGY

  • Cancer
  • Lymphoma
  • European Union
  • Japan
  • United States

NHL: Mantle Cell Lymphoma Disease Coverage Forecast and Market Analysis to 2034

  • $ 22000
  • April 2018
  • 196 pages

NHL: Mantle Cell Lymphoma Disease Coverage Forecast and Market Analysis to 2034 TABLE OF CONTENTS & nbsp; (Forecast, Treatment and Epidemiology Datapacks included) & nbsp; ## FORECAST: MANTLE CELL LYMPHOMA (Published on ## April 2016) ## OVERVIEW ## EXECUTIVE SUMMARY ## MARKET

  • Cancer
  • Lymphoma
  • Pathology
  • European Union
  • United States

NHL: Diffuse Large B Cell Lymphoma Forecast and Market Analysis to 2034

  • $ 22000
  • April 2018
  • 162 pages

NHL: Diffuse Large B Cell Lymphoma Forecast and Market Analysis to 2034 TABLE OF CONTENTS & nbsp; (Forecast, Treatment, Epidemiology Datapacks included) & nbsp; ## FORECAST: DIFFUSE LARGE B-CELL LYMPHOMA (Published on ## August 2016) ## OVERVIEW ## EXECUTIVE SUMMARY ## MARKET OVE

  • Cancer
  • Lymphoma
  • European Union
  • Japan
  • United States

Betalutin

  • $ 10000
  • January 2019
  • 17 pages

CD## is highly expressed in B cells and B-cell lymphomas.

  • Cancer
  • Lymphoma
  • Pathology
  • European Union
  • United States

Aliqopa

  • $ 10000
  • January 2019
  • 18 pages

Aliqopa CONTENTS ## OVERVIEW ## Drug Overview ## Product Profiles ## Aliqopa : NHL: Follicular lymphoma (FL) LIST OF FIGURES ## Figure ##: Aliqopa for follicular lymphoma – SWOT analysis ## Figure ##: Datamonitor Healthcare’s drug assessment summary of Aliqopa for follicular

  • Cancer
  • Lymphoma
  • Pathology
  • Targeted Therapy
  • Therapy

INCB050465

  • $ 10000
  • January 2019
  • 16 pages

INCB## CONTENTS ## OVERVIEW ## Drug Overview ## Product Profiles ## INCB## : NHL: Follicular lymphoma (FL) LIST OF FIGURES ## Figure ##: INCB## for follicular lymphoma – SWOT analysis ## Figure ##: Datamonitor Healthcare’s drug assessment summary of INCB## for folli

  • Cancer
  • Lymphoma
  • Pathology
  • United States
  • Forecast

umbralisib

  • $ 10000
  • January 2019
  • 26 pages

umbralisib CONTENTS ## OVERVIEW ## Drug Overview ## Product Profiles ## umbralisib : NHL: Follicular lymphoma (FL) ## umbralisib : NHL: Diffuse large B-cell lymphoma (DLBCL) LIST OF FIGURES ## Figure ##: Umbralisib for follicular lymphoma – SWOT analysis ## Figure ##: Datamo

  • Cancer
  • Lymphoma
  • Pathology
  • European Union
  • United States

lisocabtagene maraleucel

  • $ 10000
  • January 2019
  • 30 pages

lisocabtagene maraleucel CONTENTS ## OVERVIEW ## Drug Overview ## Product Profiles ## lisocabtagene maraleucel : NHL: Follicular lymphoma (FL) ## lisocabtagene maraleucel : NHL: Diffuse large B-cell lymphoma (DLBCL) LIST OF FIGURES ## Figure ##: Lisocabtagene maraleucel for follicula

  • Cancer
  • Immunotherapy
  • Lymphoma
  • Medical Biotechnology
  • Pathology

Yescarta

  • $ 10000
  • January 2019
  • 19 pages

Yescarta CONTENTS ## OVERVIEW ## Drug Overview ## Product Profiles ## Yescarta : NHL: Follicular lymphoma (FL) ## Yescarta : NHL: Diffuse large B-cell lymphoma (DLBCL) LIST OF FIGURES ## Figure ##: Yescarta for follicular lymphoma – SWOT analysis ## Figure ##: Datamonitor H

  • Cancer
  • Immunotherapy
  • Lymphoma
  • Medical Biotechnology
  • Pathology
View report >

Lymphoma Statistics in the UK

  • January 2018
  • 6 pages

(observed and ##. ##% five years from a lymphoma diagnosis in 2009-2013.

  • Cancer
  • Lymphoma
  • United Kingdom
  • Demographic

Lymphoma Statistics December 2019

Lymphoma Statistics December 2019

Lymphoma Statistics December 2019

Lymphoma Statistics December 2019

Lymphoma Statistics December 2019

Reportlinker.com © Copyright 2020. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on